Genomic Health, Inc announced worldwide commercial availability of its Oncotype DX colon cancer test, the first multigene expression test developed for the assessment of risk of recurrence in patients with stage II disease.
Read MoreAbaxis, Inc, a medical products company manufacturing point-of-care blood analysis systems, today announced that the U.S. Food and Drug Administration (FDA) has granted 510K marketing clearance of the new C-Reactive Protein (CRP) assay when used by healthcare professionals in conjunction with the Piccolo Xpress point-of-care analyzer.
Read MoreThe Food and Drug Administration (FDA) announced a public meeting entitled: Clinical Accuracy Requirements for Point of Care Blood Glucose Meters.
Read MoreResearch and Markets announced the addition of the “2010 Worldwide Medical Laboratories Industry Report” report to their offering.
Read MoreRosetta Genomics Ltd, a developer of microRNA-based molecular diagnostics, announced that it has completed its registered direct offering with several institutional investors of approximately $5.1 million of securities.
Read More